Skip to main content

Volume 12 - Issue 12 - December 2012

Feature

Perspectives
12/04/2012
As a profession, medicine continues to lag behind other major industries in the adoption of social media. However, change is coming.
As a profession, medicine continues to lag behind other major industries in the adoption of social media. However, change is coming.
As a profession, medicine...
12/04/2012
EP Lab Digest
Feature Story
12/04/2012
The authors outline various operational considerations for Biosense Webster’s PentaRay NAV catheter, as well as present a case study describing clinical considerations. 
The authors outline various operational considerations for Biosense Webster’s PentaRay NAV catheter, as well as present a case study describing clinical considerations. 
The authors outline various...
12/04/2012
EP Lab Digest

Column

Feature Interview
12/04/2012
EPLD speaks with Dr. Rachel Lampert about newly published research on patient attitudes and perceptions regarding primary prophylaxis with implantable cardioverter-defibrillators.
EPLD speaks with Dr. Rachel Lampert about newly published research on patient attitudes and perceptions regarding primary prophylaxis with implantable cardioverter-defibrillators.
EPLD speaks with Dr. Rachel...
12/04/2012
EP Lab Digest
Spotlight Interview
12/04/2012
Mission Hospital is a 407-bed, acute care, full-service facility, and one of only three trauma centers in the area. This non-profit organization, which is part of the St. Joseph Health System, commits ten percent of its net income to programs...
Mission Hospital is a 407-bed, acute care, full-service facility, and one of only three trauma centers in the area. This non-profit organization, which is part of the St. Joseph Health System, commits ten percent of its net income to programs...
Mission Hospital is a 407-bed,...
12/04/2012
EP Lab Digest
Feature Interview
12/04/2012
PulsePredic is a new blood test that helps determine who benefits most from an ICD. In this interview, EPLD speaks with Dr. Dudley, President and CEO of ROS Technologies, the innovator in the development of this blood test. 
PulsePredic is a new blood test that helps determine who benefits most from an ICD. In this interview, EPLD speaks with Dr. Dudley, President and CEO of ROS Technologies, the innovator in the development of this blood test. 
PulsePredic is a new blood test...
12/04/2012
EP Lab Digest
Letter from the Editor
12/04/2012
It is impressive how much impact 2 statisticians had on so many disciplines when they published a paper in a statistical journal in 1958.
It is impressive how much impact 2 statisticians had on so many disciplines when they published a paper in a statistical journal in 1958.
It is impressive how much impact...
12/04/2012
EP Lab Digest

Department

SICP Section
12/04/2012
Monthly update from the Society of Invasive Cardiovascular Professionals.
Monthly update from the Society of Invasive Cardiovascular Professionals.
Monthly update from the Society...
12/04/2012
EP Lab Digest